The differential diagnosis and management of Cushing's syndrome remain difficult, particularly for ectopic adrenocorticotropin (ACTH) syndromes resulting from small bronchial carcinoids. We report the case of a 41-year-old man with ectopic ACTH-dependent Cushing's syndrome. Two computed tomography scans of the thorax were normal and magnetic resonance imaging ofthe chest showed a 6-mm hyperintense Ti-weighted area close to the left pulmonary hilus, interpreted as probably vascular by the radiologists. An ['I..n-DTPA-D-Phe']octreotide scintigraphy scan demonstrated a positive image for somatostatin receptors in exactly the same location and surgery confirmed the presence of a small ACTH-secreting carcinoid tumour in the upper left lung lobe which was resected. Surgery cured the hypercorticism of the patient. The differential diagnosis of Cushing's syndrome and the procedure for localisation of an ACTH source are discussed.
Summary
The differential diagnosis and management of Cushing's syndrome remain difficult, particularly for ectopic adrenocorticotropin (ACTH) syndromes resulting from small bronchial carcinoids. We report the case of a 41-year-old man with ectopic ACTH-dependent Cushing's syndrome. Two computed tomography scans of the thorax were normal and magnetic resonance imaging ofthe chest showed a 6-mm hyperintense Ti-weighted area close to the left pulmonary hilus, interpreted as probably vascular by the radiologists. An ['I..n-DTPA-D-Phe']octreotide scintigraphy scan demonstrated a positive image for somatostatin receptors in exactly the same location and surgery confirmed the presence of a small ACTH-secreting carcinoid tumour in the upper left lung lobe which was resected. Surgery cured the hypercorticism of the patient. The differential diagnosis of Cushing's syndrome and the procedure for localisation of an ACTH source are discussed. Keywords . Urinary dopamine, epinephrine, norepinephrine, metanephrine and normetanephrine were normal. Under a standard low-and high-dose dexamethasone suppression test (Liddle test), serum cortisol decreased from 731 nmol/l at baseline to 552 nmol/l after dexamethasone 2 mg/day and to 207 nmol/l after dexamethasone 8 mg/day. Urinary 17-hydroxycorticosteroids were reduced sequentially from 89 jtmol/day to 53 ,umol/day and thence to 21 pmol/day. A corticotropin-releasing factor (CRF) test (100 ,ug intravenously) showed a 24% increase in ACTH (from 13 to 16 pmol/l) and a 16% increase in serum cortisol (from 662 to 773 nmol/l). A short metyrapone test (500 mg/h for six hours) raised ACTH to 583% of baseline (from 13 to 92 pmol/l), serum 1 1-deoxycortisol to 125% of baseline (from 6.1 to 765 nmol/l) and stimulated 17-hydroxycorticosteroid secretion by 2.75 (from 78 to 215 jmol/d). These data demonstrated an ACTH-dependent nonsuppressible hypercorticism, unresponsive to CRF but potently stimulated by metyrapone. MRI of the hypothalamic and pituitary regions without and with gadolinium contrast was normal and bilateral inferior petrosal venous sinus sampling after CRF stimulation showed no ACTH concentration gradient between the inferior petrosal venous sinus samples and peripheral blood.
An abdominal CT scan was normal, as well as two CT scans of the chest (5-mm sections), bronchial arteriography, bronchoscopic examination and positron emission tomography of the thorax (methionine and fluorodeoxyglucose). MRI of the thorax showed a 6-mm nodular lesion in the left upper pulmonary lobe close to the hilus which was interpreted as a venous component. An [1' In-DTPA-DPhel]octreotide planar scintigraphy scan revealed a small spot of octreotide uptake in the left lung supra-hilar region. A single octreotide administration (100 ,ug subcutaneously) was, however, not followed by any ACTH suppression (measured every 2 h for 16 h after administration of the drug). No single endocrinological test affords complete discrimination between both types of Cushing's syndrome, and multiple testing has often to be performed to identify the ACTH source.' High doses of glucocorticoids usually suppress ACTH and cortisol production in pituitary Cushing's syndrome but not in adrenal and ectopic ACTH secretion syndrome. Serum cortisol decreased significantly after dexamethasone 8 mg/day in our patient but remained above the 5 pig/dl level, which is generally accepted as a good criterion of suppression. Pituitary ACTHsecreting adenomas are usually hypersensitive to CRH, most of them showing an exaggerated ACTH response. In our case, CRH administration did not increase serum ACTH by more than 24% and serum cortisol by more than 16% from baseline, far less than the 50% and 20% increases for serum ACTH and cortisol, respectively, accepted as an exaggerated response.7
These two tests suggest a non-pituitary ACTH source. ACTH-secreting pituitary adenomas remain generally sensitive to the inhibitory effect of cortisol on the hypothalamic-pituitaryadrenal axis, while adrenal tumours and ectopic ACTH-secreting tumours are not. Under the action of metyrapone, most ACTH-secreting pituitary adenomas show an increase in 17-hydroxycorticosteroid secretion of at least 200% ofbaseline and a 1 1-deoxycortisol raised over 10 ,ug/dl.6 In our patient the response of 11-deoxycortisol fulfilled the criteria of a pituitary ACTH-secreting adenoma, but a recent review of the metyrapone test showed that at least 400-fold increases of 11-deoxycortisol are necessary to exclude an ectopic ACTH source.6 Finally, inferior petrosal venous sinus sampling after CRH stimulation, known to show a sensitivity and specificity of almost 100% in the correct diagnosis of Cushing's disease,4 practically excluded the presence of a pituitary ACTHsecreting adenoma in our patient.
Routine clinical and radiological investigations, including CT of the abdomen and chest, failed to localise the tumoural source of the ACTH. Most occult tumours producing ACTH are small carcinoids located inside the thorax.' Classical endocrine work-up in these tumours can be very misleading, up to 93% showing pituitary-like behaviour and only a few high urinary 5-HIAA excretion.' MRI has been recognised as being more sensitive than CT in detecting small pulmonary carcinoids arising in the close vicinity of the pulmonary hilus.8 In our patient, MRI of the chest showed a small area of increased Ti intensity close to the left hilus, but the radiologist could not differentiate it from parahilar venous structures. 
Conclusion
Management of Cushing's syndrome has always been a difficult problem. Since the generalisation of inferior petrosal sinus sampling for ACTH, with or without ovine CRH stimulation, the differentiation between pituitary ACTHdependent and non-pituitary ACTH-dependent Cushing's syndrome has been greatly improved. However, localisation of the ACTH source in documented ectopic Cushing's syndrome produced by occult tumours (particularly carcinoids) still remains very difficult. We show that ["'In-DTPA-D-Phe']octreotide scintigraphy can be sensitive and anatomically accurate in the localisation of lesions with negative or ambiguous radiological work-up and may allow early curative surgery.
